The abstract is read at the publisher; the summary is JClub's.
Activating auricular TRPV1+ vagal afferents suppresses Alternaria alternata-induced type 2 allergic airway inflammation, reducing group 2 innate lymphoid cells, eosinophils, and type 2 cytokine responses.
- Why it matters: It remains unclear whether external (exteroceptive) signals can regulate visceral neuroimmune inflammation, beyond known interoceptive vagal control.
- What they did: Using viral and chemical neural tracing, the study mapped distinct vagal ganglia projections to auricular skin, then used pharmacologic, chemogenetic, and optogenetic stimulation of auricular TRPV1+ afferents; silencing these neurons worsened inflammation, and CGRPβ dependence was tested.
- The result: The auricular skin–lung reflex links exteroceptive inputs to visceral inflammation control, implying that transcutaneous neuromodulation could be a therapeutic strategy for allergic airway inflammation.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.